{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:03:58Z","timestamp":1789916638442,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.neuropharm.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T23:53:58Z","timestamp":1546991638000},"page":"178-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention"],"prefix":"10.1016","volume":"148","author":[{"given":"Courtney A.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary D.","family":"Brodnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole V.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten E.A.","family":"Reith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed S.","family":"Shumsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2086-4290","authenticated-orcid":false,"given":"Barry D.","family":"Waterhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-8669","authenticated-orcid":false,"given":"Sandhya","family":"Kortagere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuropharm.2019.01.003_bib1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11064-014-1275-5","article-title":"Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats","volume":"39","author":"Ago","year":"2014","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2019.01.003_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/07448480009596296","article-title":"Student perceptions of methylphenidate abuse at a public liberal arts college","volume":"49","author":"Babcock","year":"2000","journal-title":"J. Am. Coll. Health"},{"issue":"1","key":"10.1016\/j.neuropharm.2019.01.003_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00213-013-3141-6","article-title":"Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD","volume":"230","author":"Bari","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neuropharm.2019.01.003_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jcpp.12272","article-title":"Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit\/hyperactivity disorder","volume":"56","author":"Bedard","year":"2015","journal-title":"J. Child Psychol. Psychiatr."},{"issue":"10","key":"10.1016\/j.neuropharm.2019.01.003_bib5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biopsych.2006.04.022","article-title":"Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function","volume":"60","author":"Berridge","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuropharm.2019.01.003_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.biopsych.2011.07.022","article-title":"Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic alpha(1) - and alpha(2)-receptors","volume":"71","author":"Berridge","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neuropharm.2019.01.003_bib7","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1038\/npp.2008.18","article-title":"Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine","volume":"33","author":"Briand","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2019.01.003_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuint.2012.07.012","article-title":"Increased tyrosine availability increases brain regional DOPA levels in vivo","volume":"61","author":"Brodnik","year":"2012","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.neuropharm.2019.01.003_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00213-013-2977-0","article-title":"Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion","volume":"227","author":"Brodnik","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neuropharm.2019.01.003_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1570159X13666150407225902","article-title":"From clinical application to cognitive enhancement: the example of methylphenidate","volume":"14","author":"Busardo","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2019.01.003_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2019.01.003_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1369-1600.2012.00456.x","article-title":"Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations","volume":"19","author":"Calipari","year":"2014","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2019.01.003_bib13","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1038\/ncomms3720","article-title":"Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression","volume":"4","author":"Calipari","year":"2013","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neuropharm.2019.01.003_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.1990.tb04599.x","article-title":"Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals","volume":"55","author":"Carboni","year":"1990","journal-title":"J. Neurochem."},{"issue":"23","key":"10.1016\/j.neuropharm.2019.01.003_bib50","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2019.01.003_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.brainres.2015.11.039","article-title":"Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasks","volume":"1641","author":"Chu","year":"2016","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2019.01.003_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1037\/0894-4105.13.1.135","article-title":"Concept formation and concept shifting in frontal lesion and Parkinson's disease patients assessed with the California Card Sorting Test","volume":"13","author":"Dimitrov","year":"1999","journal-title":"Neuropsychology"},{"issue":"5","key":"10.1016\/j.neuropharm.2019.01.003_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00004714-200210000-00005","article-title":"Comparative efficacy of Adderall and methylphenidate in attention-deficit\/hyperactivity disorder: a meta-analysis","volume":"22","author":"Faraone","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2019.01.003_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00213-010-1823-x","article-title":"Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study","volume":"210","author":"Finke","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"6566","key":"10.1016\/j.neuropharm.2019.01.003_bib19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neuropharm.2019.01.003_bib20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.biopsych.2010.06.017","article-title":"Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo","volume":"68","author":"Hannestad","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2019.01.003_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejphar.2013.09.035","article-title":"Effects of the neurotensin NTS(1) receptor agonist PD149163 on visual signal detection in rats","volume":"721","author":"Hillhouse","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2019.01.003_bib22","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.clinbiochem.2010.04.071","article-title":"A recursive version of Grubbs' test for detecting multiple outliers in environmental and chemical data","volume":"43","author":"Jain","year":"2010","journal-title":"Clin. Biochem."},{"issue":"11","key":"10.1016\/j.neuropharm.2019.01.003_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1101\/lm.026302.112","article-title":"Medial prefrontal lesions in mice impair sustained attention but spare maintenance of information in working memory","volume":"19","author":"Kahn","year":"2012","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2019.01.003_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbr.2014.08.026","article-title":"The spontaneously hypertensive rat\/Izm (SHR\/Izm) shows attention deficit\/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate","volume":"274","author":"Kishikawa","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2019.01.003_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.parkreldis.2010.01.003","article-title":"Attentional and perceptual impairments in Parkinson's disease with visual hallucinations","volume":"16","author":"Koerts","year":"2010","journal-title":"Park. Relat. Disord."},{"issue":"6","key":"10.1016\/j.neuropharm.2019.01.003_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.159.6.975","article-title":"Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers","volume":"159","author":"Liu","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neuropharm.2019.01.003_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00004583-199907000-00010","article-title":"Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit\/hyperactivity disorder","volume":"38","author":"Manos","year":"1999","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2019.01.003_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02246109","article-title":"Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands","volume":"117","author":"McGaughy","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.neuropharm.2019.01.003_bib29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.euroneuro.2013.05.006","article-title":"The potential role of dopamine D(3) receptor neurotransmission in cognition","volume":"23","author":"Nakajima","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Pt 6","key":"10.1016\/j.neuropharm.2019.01.003_bib30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/brain\/115.6.1727","article-title":"Fronto-striatal cognitive deficits at different stages of Parkinson's disease","volume":"115","author":"Owen","year":"1992","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neuropharm.2019.01.003_bib31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ageing\/afs084","article-title":"Sleepiness, parkinsonian features and sustained attention in mild Alzheimer's disease","volume":"41","author":"Park","year":"2012","journal-title":"Age Ageing"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2019.01.003_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00213-008-1384-4","article-title":"Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2\/3) receptor antagonist sulpiride","volume":"202","author":"Pezze","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.neuropharm.2019.01.003_bib33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0091-3057(96)00408-X","article-title":"Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat","volume":"56","author":"Puumala","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2019.01.003_bib34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0269881113513850","article-title":"Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats","volume":"28","author":"Rowley","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.003_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1744-9081-7-6","article-title":"Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit\/Hyperactivity Disorder (ADHD)","volume":"7","author":"Sagvolden","year":"2011","journal-title":"Behav. Brain Funct."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2019.01.003_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0166-4328(88)90050-2","article-title":"Vasopressin and amphetamine, but not desglycinamide vasopressin, impair positively reinforced visual attention performance in rats","volume":"29","author":"Sahgal","year":"1988","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2019.01.003_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-0173(01)00044-3","article-title":"The cognitive neuroscience of sustained attention: where top-down meets bottom-up","volume":"35","author":"Sarter","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"11","key":"10.1016\/j.neuropharm.2019.01.003_bib38","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1523\/JNEUROSCI.08-11-04049.1988","article-title":"Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior","volume":"8","author":"Selemon","year":"1988","journal-title":"J. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2019.01.003_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00213-004-2004-6","article-title":"Deficits in a sustained attention task following nicotine withdrawal in rats","volume":"178","author":"Shoaib","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.neuropharm.2019.01.003_bib40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40263-013-0102-x","article-title":"Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit\/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology","volume":"27","author":"Sikirica","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2019.01.003_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2015.04.004","article-title":"In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson's disease","volume":"100","author":"Simms","year":"2016","journal-title":"Neuropharmacology"},{"issue":"6289","key":"10.1016\/j.neuropharm.2019.01.003_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2019.01.003_bib43","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.neuron.2014.08.011","article-title":"Insights into human behavior from lesions to the prefrontal cortex","volume":"83","author":"Szczepanski","year":"2014","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuropharm.2019.01.003_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.vascn.2014.02.002","article-title":"Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models","volume":"70","author":"Teuns","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"4","key":"10.1016\/j.neuropharm.2019.01.003_bib45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.euroneuro.2014.11.016","article-title":"Putative therapeutic targets for symptom subtypes of adult ADHD: D4 receptor agonism and COMT inhibition improve attention and response inhibition in a novel translational animal model","volume":"25","author":"Tomlinson","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2019.01.003_bib46","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1523\/JNEUROSCI.0623-13.2014","article-title":"Chronic alcohol disrupts dopamine receptor activity and the cognitive function of the medial prefrontal cortex","volume":"34","author":"Trantham-Davidson","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.003_bib47","doi-asserted-by":"crossref","first-page":"43101","DOI":"10.1038\/srep43101","article-title":"Persistent neuronal activity in anterior cingulate cortex correlates with sustained attention in rats regardless of sensory modality","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2019.01.003_bib48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/acschemneuro.6b00221","article-title":"Functional characterization of a novel series of biased signaling dopamine D3 receptor agonists","volume":"8","author":"Xu","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2019.01.003_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbr.2011.03.054","article-title":"The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: separating response inhibition from premature responding","volume":"222","author":"Young","year":"2011","journal-title":"Behav. Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819300024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819300024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T09:46:46Z","timestamp":1552643206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819300024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":50,"alternative-id":["S0028390819300024"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.01.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}